Literature DB >> 28819873

Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

B A Cunha1,2, J Baron3,4, C B Cunha5,6.   

Abstract

Doxycycline and, to a lesser extent, minocycline, have been used for decades to treat various serious systemic infections, but many physicians remain unfamiliar with their spectrum, interpretation of susceptibility results, pharmacokinetic/pharmacodynamic (PK/PD) properties, optimal dosing regimens, and their activity against MRSA, VRE, and multidrug-resistant (MDR) Gram-negative bacilli, e.g., Acinetobacter sp. This article reviews the optimal use of doxycycline and minocycline to treat a variety of infections and when minocycline is preferred instead of doxycycline.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28819873     DOI: 10.1007/s10096-017-3081-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  53 in total

1.  MRSA meningitis in postoperative patients. Report of 4 cases.

Authors:  T Sakamoto; K Kikuchi; K Mineura; M Kowada; O Nakagomi
Journal:  Jpn J Antibiot       Date:  1990-06

Review 2.  A review of intravenous minocycline for treatment of multidrug-resistant Acinetobacter infections.

Authors:  David J Ritchie; Alexandria Garavaglia-Wilson
Journal:  Clin Infect Dis       Date:  2014-12-01       Impact factor: 9.079

Review 3.  Doxycycline.

Authors:  B A Cunha; C M Sibley; A M Ristuccia
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

Review 4.  Minocycline.

Authors:  M Jonas; B A Cunha
Journal:  Ther Drug Monit       Date:  1982       Impact factor: 3.681

5.  Contemporary tetracycline susceptibility testing: doxycycline MIC methods and interpretive criteria (CLSI and EUCAST) performance when testing Gram-positive pathogens.

Authors:  Ronald N Jones; Matthew G Stilwell; Michael L Wilson; Rodrigo E Mendes
Journal:  Diagn Microbiol Infect Dis       Date:  2013-03-13       Impact factor: 2.803

Review 6.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739

7.  Minocycline versus vancomycin for treatment of experimental endocarditis caused by oxacillin-resistant Staphylococcus aureus.

Authors:  D P Nicolau; C D Freeman; C H Nightingale; C J Coe; R Quintiliani
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

8.  Development of doxycycline MIC and disk diffusion interpretive breakpoints and revision of tetracycline breakpoints for Streptococcus pneumoniae.

Authors:  Steven D Dallas; Lesley McGee; Brandi Limbago; Jean B Patel; M Leticia McElmeel; Letitia C Fulcher; David R Lonsway; James H Jorgensen
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

Review 9.  Minocycline as A Substitute for Doxycycline in Targeted Scenarios: A Systematic Review.

Authors:  Nicholas W Carris; Joe Pardo; Jose Montero; Kristy M Shaeer
Journal:  Open Forum Infect Dis       Date:  2015-11-25       Impact factor: 3.835

10.  Antimicrobial stewardship programs (ASPs): the devil is in the details.

Authors:  Cheston B Cunha; Christy A Varughese; Eleftherios Mylonakis
Journal:  Virulence       Date:  2013-02-04       Impact factor: 5.882

View more
  4 in total

Review 1.  SARECYCLINE AND THE NARROW-SPECTRUM TETRACYCLINE CONCEPT: Currently Available Data and Potential Clinical Relevance in Dermatology.

Authors:  James Q Del Rosso
Journal:  J Clin Aesthet Dermatol       Date:  2020-10-01

Review 2.  Can tetracyclines ensure help in multiple sclerosis immunotherapy?

Authors:  Pedro Víctor-Carvalho; Rodolfo Thome; Catarina Rapôso
Journal:  J Clin Transl Res       Date:  2021-02-03

3.  Differential effects of minocycline on microvascular complications in murine models of type 1 and type 2 diabetes.

Authors:  Stephanie A Eid; Phillipe D O'Brien; Lucy M Hinder; John M Hayes; Faye E Mendelson; Hongyu Zhang; Samanthi Narayanan; Steven F Abcouwer; Frank C Brosius; Subramaniam Pennathur; Masha G Savelieff; Eva L Feldman
Journal:  J Transl Sci       Date:  2020-06-16

4.  Induction of Different Sensitization Patterns of MRSA to Antibiotics Using Electroporation.

Authors:  Vitalij Novickij; Jurgita Švedienė; Algimantas Paškevičius; Svetlana Markovskaja; Eglė Lastauskienė; Auksė Zinkevičienė; Irutė Girkontaitė; Jurij Novickij
Journal:  Molecules       Date:  2018-07-20       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.